LONG-TERM TREATMENT WITH TOFACITINIB IN SEVERE ALOPECIA AREATA: AN UPDATE.
作者信息
Hogan Sara, Wang Sophie, Ibrahim Omer, Piliang Melissa, Bergfeld Wilma
机构信息
All authors are with the Department of Dermatology at the Cleveland Clinic Foundation in Cleveland, Ohio.
出版信息
J Clin Aesthet Dermatol. 2019 Jun;12(6):12-14. Epub 2019 Jun 1.
Abstract
摘要
相似文献
1
LONG-TERM TREATMENT WITH TOFACITINIB IN SEVERE ALOPECIA AREATA: AN UPDATE.托法替布治疗重度斑秃的长期疗效：最新进展
J Clin Aesthet Dermatol. 2019 Jun;12(6):12-14. Epub 2019 Jun 1.
2
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.托法替尼治疗严重斑秃及其变异型：90 例患者研究。
J Am Acad Dermatol. 2017 Jan;76(1):22-28. doi: 10.1016/j.jaad.2016.09.007. Epub 2016 Nov 2.
3
Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.口服或外用托法替布成功治疗重度斑秃
J Drugs Dermatol. 2018 Jul 1;17(7):800-803.
4
Tofacitinib as a treatment of alopecia areata in adolescents.托法替布治疗青少年斑秃
Bol Med Hosp Infant Mex. 2019;76(4):182-187. doi: 10.24875/BMHIM.19000005.
5
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis.托法替布治疗全秃的短期疗效
Case Rep Dermatol. 2016 Apr 22;8(1):102-6. doi: 10.1159/000445182. eCollection 2016 Jan-Apr.
6
Tofacitinib for the treatment of alopecia areata and variants in adolescents.托法替尼治疗青少年斑秃及变异型。
J Am Acad Dermatol. 2017 Jan;76(1):29-32. doi: 10.1016/j.jaad.2016.09.006. Epub 2016 Nov 2.
7
Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents.托法替布用于治疗成人和青少年重度斑秃
J Investig Dermatol Symp Proc. 2018 Jan;19(1):S18-S20. doi: 10.1016/j.jisp.2017.10.003.
8
[JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].用于治疗斑秃的JAK抑制剂
Harefuah. 2020 Jan;159(1):38-42.
9
Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib.口服托法替布治疗中重度斑秃患者的指甲受累情况。
J Dermatolog Treat. 2018 Dec;29(8):819-822. doi: 10.1080/09546634.2018.1466024. Epub 2018 May 7.
10
Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes.用于治疗影响睫毛的斑秃的外用托法替布溶液。
JAAD Case Rep. 2018 Oct 30;4(10):988-989. doi: 10.1016/j.jdcr.2018.07.018. eCollection 2018 Nov.
引用本文的文献
1
Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.口服托法替布治疗斑秃、全秃和普秃的疗效。
Cureus. 2025 Apr 18;17(4):e82536. doi: 10.7759/cureus.82536. eCollection 2025 Apr.
2
Drug-Induced Hair Loss: Analysis of the Food and Drug Administration's Adverse Events Reporting System Database.药物性脱发：对美国食品药品监督管理局不良事件报告系统数据库的分析
Skin Appendage Disord. 2025 Feb;11(1):63-69. doi: 10.1159/000540104. Epub 2024 Jul 29.
3
Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review.中度至重度斑秃的治疗：系统叙述性综述
Dermatol Ther (Heidelb). 2023 Dec;13(12):2951-2991. doi: 10.1007/s13555-023-01044-5. Epub 2023 Oct 13.
4
Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review.托法替尼治疗青春期前斑秃的疗效：回顾性病例系列及文献复习。
Acta Derm Venereol. 2023 Sep 20;103:adv13418. doi: 10.2340/actadv.v103.13418.
5
Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review.Janus 激酶抑制剂在斑秃患者中的安全性：系统评价。
Clin Drug Investig. 2023 May;43(5):325-334. doi: 10.1007/s40261-023-01260-z. Epub 2023 May 3.
6
Effects of Isosakuranetin on Pharmacokinetic Changes of Tofacitinib in Rats with -Dimethylnitrosamine-Induced Liver Cirrhosis.异樱花素对二甲基亚硝胺诱导的肝硬化大鼠托法替布药代动力学变化的影响
Pharmaceutics. 2022 Dec 1;14(12):2684. doi: 10.3390/pharmaceutics14122684.
7
Clinical response to oral tofacitinib in pediatric patients with alopecia areata.托法替布口服治疗儿童斑秃的临床反应。
JAAD Case Rep. 2022 Aug 23;31:83-88. doi: 10.1016/j.jdcr.2022.08.024. eCollection 2023 Jan.
8
Effectiveness of Oral Tofacitinib Dose Tapering in a Case of Alopecia Areata Universalis.托法替布口服剂量递减治疗全秃一例的疗效
Skin Appendage Disord. 2021 Jan;7(1):36-40. doi: 10.1159/000510673. Epub 2020 Sep 30.
9
Clinical Experience with Oral Tofacitinib in a Patient with Alopecia Areata Universalis and Rheumatoid Arthritis.托法替布口服治疗全秃型斑秃合并类风湿关节炎的临床经验
Int J Trichology. 2020 Jul-Aug;12(4):188-190. doi: 10.4103/ijt.ijt_107_20. Epub 2020 Sep 19.
本文引用的文献
1
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.一项开放性标签试验，旨在评估托法替尼治疗中度至重度斑状型斑秃、全秃和普秃的疗效。
J Invest Dermatol. 2018 Jul;138(7):1539-1545. doi: 10.1016/j.jid.2018.01.032. Epub 2018 Feb 13.
2
Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series.韩国难治性中度至重度斑秃患者口服托法替布单药治疗：病例系列
J Am Acad Dermatol. 2017 Nov;77(5):978-980. doi: 10.1016/j.jaad.2017.06.027.
3
Treatment of Alopecia Areata With Tofacitinib.他卡西醇治疗斑秃。
JAMA Dermatol. 2017 Jun 1;153(6):600-602. doi: 10.1001/jamadermatol.2017.0001.
4
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.托法替尼治疗严重斑秃及其变异型：90 例患者研究。
J Am Acad Dermatol. 2017 Jan;76(1):22-28. doi: 10.1016/j.jaad.2016.09.007. Epub 2016 Nov 2.
5
Tofacitinib for the treatment of alopecia areata and variants in adolescents.托法替尼治疗青少年斑秃及变异型。
J Am Acad Dermatol. 2017 Jan;76(1):29-32. doi: 10.1016/j.jaad.2016.09.006. Epub 2016 Nov 2.
6
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.托法替尼枸橼酸盐治疗斑秃患者的安全性和疗效。
JCI Insight. 2016 Sep 22;1(15):e89776. doi: 10.1172/jci.insight.89776.
Zotero 插件